Clinical trials: Severe Aplastic Anemia, open to volunteers

Severe Aplastic Anemia

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

• Recruiting
• Age: 3 to 99 years
• Phase 2
• Pill or oral medicine
• Injection or infusion
• Results posted

Background: Severe aplastic anemia (SAA) is a rare and serious blood disorder. It causes the immune system to turn against bone marrow cells.

Trial name

NCT04304820

Testing

Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin

Where

United States

Volunteers

80 people

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)